Your browser doesn't support javascript.
loading
CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.
Gifford, Alex H; Heltshe, Sonya L; Goss, Christopher H.
Affiliation
  • Gifford AH; 1 Division of Pulmonary and Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Heltshe SL; 2 Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
  • Goss CH; 3 CFF Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington; and.
Ann Am Thorac Soc ; 16(3): 331-340, 2019 03.
Article in En | MEDLINE | ID: mdl-30580531

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemoglobins / Cystic Fibrosis Transmembrane Conductance Regulator / Cystic Fibrosis / Anemia / Mutation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Ann Am Thorac Soc Year: 2019 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemoglobins / Cystic Fibrosis Transmembrane Conductance Regulator / Cystic Fibrosis / Anemia / Mutation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Ann Am Thorac Soc Year: 2019 Document type: Article Country of publication: United States